[The efficacy of systemic thrombolysis in patients with cardioembolic stroke].

Aim: To compare the efficacy and safety of systemic thrombolytic therapy (STLT) in patients with cardioembolic stroke (CE) versus other pathogenic subtypes of ischemic stroke (IS).

Material And Methods: The study included 147 patients, 62 women and 85 men (mean age - 62.9±0.

[Systemic thrombolytic therapy of ischemic stroke in diabetes mellitus type 2 and hyperglycemia].

Aim: Systemic thrombolytic therapy (STLT) is an available method of treatment of ischemic stroke (II) with proven efficacy. The efficacy and safety of STLT in certain groups of patients, in particular with diabetes mellitus type 2 (T2DM), are being discussed. To compare the efficacy and safety of STLC in II patients with T2DM, hyperglycemia and normoglycemia.